Diabetes, SGLT-2 Inhibitors

← Back to Class List

PDL Status Values

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required but eligible patients will encounter a co-pay at the pharmacy.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.

To request a Prior Authorization, please use this form.

Generic Name Brand Name Form PDL
Status
Current Drug Use Criteria New Drug Evaluation
canagliflozin INVOKANA TABLET N PA Document  
canagliflozin/metformin HCl INVOKAMET XR TAB BP 24H N PA Document  
canagliflozin/metformin HCl INVOKAMET TABLET N PA Document Jan 29, 2015
dapagliflozin propanediol FARXIGA TABLET N PA Document  
dapagliflozin/metformin HCl XIGDUO XR TAB BP 24H N PA Document  
dapagliflozin/saxagliptin HCl QTERN TABLET N PA Document  
empagliflozin JARDIANCE TABLET N PA Document Jan 29, 2015
empagliflozin/linagliptin GLYXAMBI TABLET N PA Document  
empagliflozin/metformin HCl SYNJARDY XR TAB BP 24H N PA Document  
empagliflozin/metformin HCl SYNJARDY TABLET N PA Document